BRKR Bruker Corp.

43.540.01 (+0.02%)
Close: September 20, 2019

Quote

Previous Close
$43.54
Day Range
$43.29-$43.86
52 Week Range
$26.10-$51.41
Volume
508,921
Avg Volume
804,060
Dividend TTM
$0.16 (0.37%)
Ex-Dividend Date
2019-08-30

Valuation

Market Cap
$6.73B
Enterprise Value (EV)
$6.75B
PE Ratio
36.08
EV/EBITDA
19.56
Price/Sales
3.55
Price/Book
7.51
PEG Ratio
1.13

Financials

Revenue
$1.90B
Gross Profit
$903.20M
EBITDA
$345.20M
EPS, ttm
$1.21
Profit Margin
9.48%
Revenue/Employee
$275.92K
Next Earnings Date
11/1/2019 (40 days)
Debt to Equity
38%
Debt
$341.10M
Cash
$322.40M
Net Debt
$18.70M

Performance

Beta
1.29
200 Day Moving Avg
$39.99
50 Day Moving Avg
$44.09
52 Week Change
32.46%
YTD Change
48.62%
1 Month Change
2.86%
3 Month Change
-10.71%
6 Month Change
8.42%
1 Year Change
32.46%
2 Year Change
69.10%
5 Year Change
110.63%

Share Count

Shares Outstanding
154.7M
Float
101.5M
Restricted Shares
53.2M
Restricted Shares, %
34.41%

Bruker Corp. Company Details

Sector: Health Technology

Industry: Medical Specialties

CEO: Frank H. Laukien

Website: http://www.bruker.com

Description: Bruker Corp. engages in the development, manufacture, and distribution of scientific instruments, and analytical and diagnostic solutions that enable customers to explore life and materials at microscopic, molecular, and cellular levels. It operates through the Bruker Scientific Instruments (BSI), and Bruker Energy and Supercon Technologies (BEST) segments. The BSI segment comprises of the Bruker BioSpin Group, the Bruker CALID Group, and the Bruker Nano Group. The BEST segment designs, manufactures, and distributes superconducting materials, primarily metallic low temperature superconductors, for use in magnetic resonance imaging, nuclear magnetic resonance, fusion energy research and other applications. The company was founded by Gunther Laukien in 1961 and is headquartered in Billerica, MA.

Employees: 6,870